[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE7501967L - - Google Patents

Info

Publication number
SE7501967L
SE7501967L SE7501967A SE7501967A SE7501967L SE 7501967 L SE7501967 L SE 7501967L SE 7501967 A SE7501967 A SE 7501967A SE 7501967 A SE7501967 A SE 7501967A SE 7501967 L SE7501967 L SE 7501967L
Authority
SE
Sweden
Prior art keywords
contg
soluble
capsule
compsns
overdosing
Prior art date
Application number
SE7501967A
Other languages
Unknown language ( )
English (en)
Other versions
SE426549B (sv
Inventor
E A Holstius
R M Cresswell
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7501967L publication Critical patent/SE7501967L/
Publication of SE426549B publication Critical patent/SE426549B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7501967A 1974-02-22 1975-02-21 Sett att framstella oralt intagbart farmaceutiskt preparat innehallande digoxin SE426549B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44496174A 1974-02-22 1974-02-22
US45300074A 1974-03-19 1974-03-19

Publications (2)

Publication Number Publication Date
SE7501967L true SE7501967L (de) 1975-08-25
SE426549B SE426549B (sv) 1983-01-31

Family

ID=27034126

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7501967A SE426549B (sv) 1974-02-22 1975-02-21 Sett att framstella oralt intagbart farmaceutiskt preparat innehallande digoxin

Country Status (14)

Country Link
JP (1) JPS50126822A (de)
AU (2) AU501549B2 (de)
CA (1) CA1096307A (de)
DE (1) DE2507635A1 (de)
ES (1) ES434971A1 (de)
FI (1) FI750489A (de)
FR (1) FR2261752B1 (de)
GB (1) GB1506016A (de)
IE (1) IE41620B1 (de)
IL (1) IL46682A (de)
IT (1) IT1233251B (de)
LU (1) LU71894A1 (de)
NL (1) NL7502121A (de)
SE (1) SE426549B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508770A (en) * 1974-04-01 1978-04-26 Scherer Ltd R Pharmaceutical compositions
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
FR2380030A1 (fr) * 1977-02-09 1978-09-08 Christiaens Sa A Composition pharmaceutique contenant de la gitoxine
IT1158722B (it) * 1977-07-08 1987-02-25 Simes Composizione farmaceutica per il trattamento delle turbe del sonno
JPS5625428U (de) * 1979-08-03 1981-03-09
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
DE3445237C1 (de) * 1984-12-12 1986-06-05 R.P. Scherer GmbH, 6930 Eberbach Weichgelatinekapseln und Verfahren zu ihrer Herstellung
DE3529694A1 (de) * 1985-08-20 1987-02-26 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1481411A (en) * 1973-07-20 1977-07-27 Scherer Ltd R Pharmaceutical compositions

Also Published As

Publication number Publication date
LU71894A1 (de) 1975-12-09
IT8349395A0 (it) 1983-11-28
IL46682A (en) 1979-07-25
FI750489A (de) 1975-08-23
IT1233251B (it) 1992-03-24
ES434971A1 (es) 1977-05-16
AU7844075A (en) 1976-08-26
DE2507635A1 (de) 1975-08-28
FR2261752A1 (de) 1975-09-19
DE2507635C2 (de) 1991-07-25
AU520082B2 (en) 1982-01-14
SE426549B (sv) 1983-01-31
FR2261752B1 (de) 1978-07-21
GB1506016A (en) 1978-04-05
IE41620B1 (en) 1980-02-13
IL46682A0 (en) 1975-04-25
JPS50126822A (de) 1975-10-06
IE41620L (en) 1975-08-22
NL7502121A (nl) 1975-08-26
CA1096307A (en) 1981-02-24
AU501549B2 (en) 1979-06-21

Similar Documents

Publication Publication Date Title
ES442579A1 (es) Procedimiento para preparar formulaciones de 1-dopa en uni- dades de dosificacion con revestimiento enterico-efervescen-te.
ES303909A1 (es) Un procedimiento para recubrir una composicion farmaceutica.
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
JPS5587716A (en) Cardiotonic glycoside containing medicine
JPS5225013A (en) Insulin pharmaceutical for nasal administration
YU48583B (sh) Postupak za pripremanje formulacije u obliku pilule za oralno davanje
IT1233251B (it) Prerarato farmaceutico a base di digossina per ingestione orale
ES443910A1 (es) Procedimiento para la preparacion de derivados de acido ben-zoico.
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
GB1459675A (en) Method for the prevention of conception
IE42950L (en) X-ray contrast preparations
Kramer Methotrexate and radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx.(Preliminary report of a controlled clinical trial of the Radiation Therapy Oncology Group)
CA2051369A1 (en) Thyroid hormone cardiac treatment
MY100780A (en) Azumolene dosage form.
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
ES447712A1 (es) Un procedimiento de preparacion de una suspension de dioxi- do de titanio.
FR2077913A1 (en) Tablets contg gelatine capsules - for administration of liquid medicaments
Jaffe et al. Effects of LSD-25 and dextroamphetamine on speech rhythms in psychotherapy dialogues.
Böszörményi Report on Experiences with Ethambutol
GB1429977A (en) Diuretic composition
FR2260995A1 (en) Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion
GB1173615A (en) Calcium Succinate
AU474224B2 (en) Copolymers of vinyl ethers and cyclic polyenes containing a system of conjugated double bonds and process forthe preparation thereof
ZA74404B (en) 4,8-dimethoxy-furo(3',2'-f)benzoxazol-2-yl acethydroxamic acid,its process of preparation and its therapeutic application
GB1354643A (en) Pharmaceutical coating composition

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7501967-9

Effective date: 19910911

Format of ref document f/p: F